IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.217
AS - Asia 6.014
EU - Europa 6.014
SA - Sud America 1.149
AF - Africa 230
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 25.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.670
SG - Singapore 3.539
RU - Federazione Russa 1.833
CN - Cina 1.685
IE - Irlanda 1.325
UA - Ucraina 1.255
BR - Brasile 1.002
IT - Italia 747
CA - Canada 477
VN - Vietnam 268
DE - Germania 185
GB - Regno Unito 135
SE - Svezia 131
KR - Corea 109
CI - Costa d'Avorio 105
IN - India 105
FR - Francia 59
NL - Olanda 58
CH - Svizzera 55
AR - Argentina 54
PL - Polonia 53
UZ - Uzbekistan 42
BD - Bangladesh 41
MX - Messico 41
FI - Finlandia 35
JP - Giappone 32
EC - Ecuador 29
TR - Turchia 28
ZA - Sudafrica 28
ES - Italia 22
AT - Austria 18
ID - Indonesia 18
GR - Grecia 17
IQ - Iraq 17
CZ - Repubblica Ceca 16
EG - Egitto 16
LB - Libano 16
NG - Nigeria 16
CO - Colombia 15
BJ - Benin 14
SN - Senegal 14
VE - Venezuela 14
BE - Belgio 13
MA - Marocco 13
RO - Romania 13
SA - Arabia Saudita 13
PE - Perù 12
TW - Taiwan 12
BG - Bulgaria 11
PK - Pakistan 11
PY - Paraguay 11
HK - Hong Kong 10
EU - Europa 8
IR - Iran 8
AU - Australia 7
JO - Giordania 7
TT - Trinidad e Tobago 7
IL - Israele 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
DZ - Algeria 5
JM - Giamaica 5
KW - Kuwait 5
KZ - Kazakistan 5
LT - Lituania 5
LY - Libia 5
MY - Malesia 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
NP - Nepal 4
CL - Cile 3
CR - Costa Rica 3
KG - Kirghizistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GY - Guiana 1
Totale 25.629
Salva come PNG Salva come JPEG
Città #
Dallas 2.530
Singapore 1.889
Dublin 1.321
Jacksonville 1.218
Santa Clara 1.169
Chandler 954
Ashburn 803
Moscow 683
Boardman 526
Nanjing 422
Andover 367
Cambridge 360
Lawrence 353
Toronto 353
Hefei 247
San Mateo 229
Des Moines 200
Chicago 192
Los Angeles 162
Wilmington 144
Beijing 139
Catania 139
Nanchang 123
Seoul 108
Abidjan 105
Hebei 98
Shenyang 95
Ho Chi Minh City 91
Saint Petersburg 84
São Paulo 83
Grafing 77
Ottawa 76
Jiaxing 75
Civitanova Marche 73
Buffalo 68
Changsha 68
Tianjin 66
New York 56
Hanoi 42
Council Bluffs 41
Warsaw 40
Rio de Janeiro 38
Bari 34
Dong Ket 30
Seattle 30
Bremen 28
Tokyo 28
Milan 26
Washington 26
Brooklyn 25
Kunming 25
Montreal 25
Norwalk 25
Phoenix 25
Redondo Beach 25
Munich 24
San Francisco 24
Palermo 23
Den Haag 22
Houston 22
Pune 21
Amsterdam 20
Belo Horizonte 20
Boston 20
Atlanta 19
Hangzhou 19
Johannesburg 19
Liberty Lake 19
Quito 19
Ann Arbor 18
Curitiba 18
Tashkent 18
Brasília 17
Abuja 16
Helsinki 16
Mumbai 16
San Jose 16
Stockholm 16
Poplar 15
Augusta 14
Cotonou 14
Dakar 14
Jinan 14
Ningbo 14
The Dalles 14
Brussels 13
Columbus 13
Kochi 13
Manchester 13
Porto Alegre 13
Mexico City 12
Orem 12
Rome 12
Charlotte 11
Denver 11
Dhaka 11
Florence 11
Haiphong 11
Hanover 11
Redwood City 11
Totale 16.978
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 454
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 185
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 181
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 175
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 169
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 161
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 152
Activation of coaugulation and fibrinolysis in laparoscopic surgery 147
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 139
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 137
A rare case of myeloid sarcoma presenting as anal fissure. 134
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 127
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 127
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 126
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 125
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 125
Activation coagulation and fibrinolysis in laparoscopic surgery 124
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 123
Activation of coagulation anf fibrinolysis in laparoscopic surgery 123
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 120
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 119
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 116
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 116
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 114
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 114
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 113
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 112
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 112
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 109
Acute lymphoblastic leukemia in elderly. 109
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 109
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 108
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 107
How to prevent intraoperative risks and complications in laparoscopic splenectomy 105
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 104
Laparoscopic splenectomy: a single center experience 103
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 103
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 102
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 102
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 102
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 101
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 100
Alteration of endothelium-coagulative system during COPD exacerbations 100
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 97
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 97
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 96
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 93
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 92
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 92
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 91
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 91
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 91
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 91
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 91
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 90
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 90
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 89
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 89
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 89
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 89
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 89
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 87
I disordini dell'emostasi nelle emopatie maligne. 87
The Antiphospholipid Syndrome 87
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 86
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 86
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 85
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 85
Immunomodulating treatment in patients with aplastic anemia. 84
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 84
Le anemie carenziali. 83
Factor-VIII-rela- ted antigen and vasculitis. 83
The antiphospholipid syndrome in pregnancy: a review article 83
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 83
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 83
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 82
Trattamento preoperatorio con interleuchina-2 nel carcinoma colorettale. 82
Unusual onset of severe varicella in adult immunocompromised patients 81
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 81
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 80
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 80
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 80
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 80
Cutaneous vasculitis in non Hodgkin's Lymphoma. 79
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 79
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 79
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 78
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 78
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 78
Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta Thalassemia: a pilot study. 77
Thymostimulin in aplastic anaemia. 77
Interleukin-8 levels in patients with essential thrombocythemia. 77
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 77
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 76
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 76
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 75
Surgical management of hereditary spherocytosis Current strategies 75
ECLAP Cooperative Group. A Randomized Trial. 74
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neolpasms 74
JAK2V6176F mutation status and thrombosis in essential thrombocytemia 74
Totale 10.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021758 0 0 0 0 0 26 198 13 287 10 163 61
2021/20222.657 346 387 21 30 429 5 394 92 282 5 63 603
2022/20233.474 365 93 28 229 348 652 4 576 971 29 115 64
2023/20241.666 81 110 73 86 65 160 160 355 17 40 230 289
2024/20255.265 38 716 369 170 1.183 404 110 201 517 689 313 555
2025/20268.507 704 595 2.641 779 2.097 1.691 0 0 0 0 0 0
Totale 26.128